Interestingly, anti-AQP4 IgGs are rarely found in the CSF of NMO patients, except during active phases of disease, suggesting that the periphery is the main source of anti-AQP4 antibodies (Jarius et al., 2010; Sato et al., 2014). Here, AQP4 is linked to neuromyelitis optica.